Forgot your password?

Forgot your username?

database > company
Biotest Biopharmaceuticals
5800 Park of Commerce Blvd., N.W.
Boca Raton, FL 33487 USA
phone:561-989-5800
fax:561-989-5801
Symbol private
Founded 2007
Employees
www.biotestpharma.com
Research Sector
Summary Description
Hyperimmune globulin
Management
Keywords
pharmaceuticals, biotherapeutic products, protein, hematology, immunology

Comment | Printable Version | Modify profile |
Updated: Jun. 02, 2009

Description
Nabi-HB [Hepatitis B Immune Globulin (Human)] is a hyperimmune globulin that contains antibodies to hepatitis B surface antigen (anti-HBs). Nabi-HB is indicated for the treatment of acute exposure to blood containing hepatitis B surface antigen (HBsAg), perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons and household exposure to persons with acute HBV infection. Hepatitis B Immune Globulin (Human) products provide passive immunization for individuals exposed to the hepatitis B virus as evidenced by a reduction in the attack rate by hepatitis B following use. Clinical studies conducted prior to 1983 with hepatitis B immune globulins similar to Nabi-HB indicate the advantage of simultaneous administration of hepatitis B Vaccine and hepatitis B Immune Globulin (Human).
Technology / Differentiation
Vaccine and antibody technologies; immunotherapy.
Market / Customers
PhosLo (calcium acetate), Nabi-HB (Hepatitis B Immune Globulin), and Aloprim (allopurinol sodium). Products focus on the treatment of hyperphosphatemia (elevated serum phosphorus levels) in patients with end-stage renal disease; the prevention of Hepatitis B infection following acute exposure to the Hepatitis B virus; and management of elevated serum and urinary uric acid levels in patients receiving chemotherapy.